의약품 폐기물 관리 시장 규모 : 폐기물 유형, 폐기물의 성질, 최종 사용자, 지역별(2026-2032년)

Pharmaceutical Waste Management Market Valuation - 2026-2032

The increasing volume of pharmaceutical waste generated globally owing mostly to population growth and improved healthcare facilities is a major concern. People are becoming more aware of the environmental and health risks associated with inappropriate pharmaceutical waste disposal. There is an increasing emphasis on proper pharmaceutical waste management to reduce these dangers while also ensuring environmental sustainability by enabling the market to surpass a revenue of USD 1662.35 Billion valued in 2024 and reach a valuation of around USD 2631.59 Billion by 2032.

Furthermore, severe rules and guidelines enforced by governments and environmental organizations governing pharmaceutical waste disposal are driving up the demand for effective pharmaceutical waste management solutions. To reduce the negative consequences of pharmaceutical waste, regulatory organizations are increasingly focusing on ensuring its safe and environmentally appropriate disposal. In addition, the pharmaceutical waste management market is being driven by the increasing adoption of advanced technologies such as high-temperature incineration, landfilling, and non-incineration methods such as chemical treatments and autoclaves. These methods facilitate the safe disposal and destruction of pharmaceutical waste lowering the environmental and health concerns associated with inappropriate disposal. The growing need for pharmaceutical waste management by enabling the market to grow at a CAGR of 5.91% from 2026 to 2032.

Pharmaceutical Waste Management Market: Definition/ Overview

Pharmaceutical waste management is the safe and efficient disposal of various types of pharmaceutical waste created during the lifecycle of pharmaceutical products. This waste consists of expired or unused medications, contaminated packaging, and other items used in the production, distribution, and administration of pharmaceuticals. The goal of pharmaceutical waste management is to reduce the environmental and health concerns associated with inappropriate disposal as well as potential harm to human health.

Pharmaceutical waste management is used in a variety of settings including pharmaceutical production plants, hospitals, clinics, pharmacies, and research organizations. These organizations generate a substantial amount of pharmaceutical waste which includes expired or unused pharmaceuticals, contaminated packaging, and laboratory chemicals. Proper waste management is critical to meeting environmental requirements, reducing pollution, and protecting public health.

How Does the Increasing Volume of Healthcare Waste Drive the Pharmaceutical Waste Management Market?

The global pharmaceutical business is rapidly expanding, resulting in increased waste output. According to the IQVIA Institute for Human Data Science, global pharmaceutical spending is expected to reach USD 1.8 Trillion by 2026, increasing at a 3-6% compound annual growth rate. According to the World Health Organization (WHO), global pharmaceutical production has expanded from 300 billion Standard Units in 1985 to more than 3 trillion Standard Units in 2020, a 10-fold increase. This expansion directly adds to the increasing volume of pharmaceutical waste that requires effective disposal.

Governments around the world are enacting harsher laws for pharmaceutical waste disposal in response to growing environmental concerns. According to the Environmental Protection Agency (EPA), over 7,000 healthcare facilities in the United States generate over 14,000 tons of hazardous pharmaceutical waste each year. According to the European Medicines Agency (EMA), environmental risk evaluations are now needed for 88% of new drug applications in the European Union, up from 10% in 2005, resulting in increased demand for proper waste management solutions.

Furthermore, the growing public awareness of the environmental and health dangers connected with inappropriate medication disposal is propelling market growth. A study published in Environmental Toxicology and Chemistry discovered that 88% of the 93 most often prescribed medications can be found in trace levels in surface, ground, and drinking water. According to the US Geological Survey, 80% of US streams contain trace levels of human pharmaceuticals. This awareness is prompting additional programs for proper disposal, such as the United States Drug Enforcement Administration's National Prescription Drug Take Back Day, which gathered 744,082 pounds of unneeded prescription medicines in October 2021 alone.

How Does the High Capital Investment Hamper the Pharmaceutical Waste Management Market?

The large capital expenditure necessary for successful pharmaceutical waste management presents a substantial barrier for hospitals, healthcare institutes, and pharmaceutical corporations. These organizations must devote significant financial resources to creating sophisticated waste management systems that comply with environmental requirements and reduce pollution. The high expense of these systems which involve advanced technologies for collecting, processing, and disposing of both hazardous and non-hazardous pharmaceutical waste put a burden on these institutions' budgets.

The high capital requirements for pharmaceutical waste management stifle market expansion by acting as a barrier to entry for smaller healthcare facilities and pharmaceutical corporations. Smaller businesses are unable to afford the large upfront expenses associated with deploying modern waste management technology and instead choose cheaper, less effective options or incorrect disposal techniques. This increases environmental contamination and endangers public health contradicting the goals of pharmaceutical waste management.

Category-Wise Acumens

How Do Increased Procedures Related to Chronic Diseases Drive the Hazardous Pharmaceutical Waste?

The hazardous segment is estimated to dominate the pharmaceutical waste management market. Chronic diseases such as cancer, diabetes, cardiovascular disease, and respiratory disorders frequently necessitate extensive and long-term medical interventions such as surgeries, chemotherapy, radiation therapy, and medication. These treatments produce a large amount of hazardous medical waste which includes contaminated sharps, chemotherapeutic medications, pathological waste, and infectious materials.

As the global frequency of chronic diseases increases due to reasons such as aging populations, sedentary lifestyles, and unhealthy dietary habits, so does the volume of hazardous medical waste generated. The increasing number of healthcare operations associated with chronic diseases is likely to have a major impact on the hazardous waste segment of the medical waste management market. Healthcare facilities such as hospitals, clinics, and specialized treatment centers must consequently establish appropriate waste management systems to properly and efficiently manage the rising volume of hazardous medical waste.

Furthermore, proper treatment of hazardous medical waste created during chronic disease operations is critical to maintaining public health and environmental safety. The regulatory rules for waste management are being edited and tightened to address the issues provided by the growing volume of hazardous medical waste. As a result, healthcare facilities are rapidly investing in innovative waste management technology and solutions to comply with these laws while reducing the environmental and health concerns connected with hazardous medical waste.

How do the Increasing Awareness and New Technologies Drive the Hospitals in the Market?

Hospitals accounted for the largest market share due to rising awareness campaigns and the introduction of new technologies. The healthcare industry is becoming more conscious of the necessity of effective medical waste management for maintaining public health and environmental safety. As a result, there has been an increase in awareness campaigns, conferences, and training sessions centered on new technology and best practices for medical waste management.

Furthermore, the introduction of new medical waste management technologies is critical to boosting the growth of the hospital and diagnostic laboratory markets. Healthcare facilities are progressively using advanced technologies to manage medical waste safely and efficiently, such as autoclaving, microwave treatment, steam sterilization, and chemical disinfection. These technologies have various benefits such as improved waste sterilization, less environmental impact, and cheaper operational costs. As a result, hospitals, diagnostic laboratories, and other healthcare facilities are expanding their investments in modern technologies to improve waste management.

Furthermore, the increasing emphasis on regulatory compliance and environmental sustainability is encouraging healthcare organizations to invest in innovative medical waste management technologies. Regulatory bodies are enforcing stricter norms and regulations for medical waste management and treatment to reduce environmental pollution and public health threats. As a result, rising awareness and the introduction of new technologies are likely to propel the end-user segment particularly hospitals and diagnostic laboratories into the medical waste management market.

Country/Region-wise Acumens

How will the Increasing Adoption of Pharmaceutical Waste Management Services Drive the Market in North America?

North America is estimated to dominate the pharmaceutical waste management market during the forecast period. North America, particularly the United States, has one of the most severe regulatory regimes for managing pharmaceutical waste. According to the US Environmental Protection Agency (EPA), over 7,000 healthcare facilities in the United States generate over 14,000 tons of hazardous pharmaceutical waste each year. The Resource Conservation and Recovery Act (RCRA) and the Hazardous Waste Pharmaceuticals Rule, which were enacted in 2019, established tight standards for pharmaceutical waste treatment, resulting in market growth in this region.

Furthermore, North Americans are becoming more conscious of the proper disposal of unused or expired drugs. The Drug Enforcement Administration's (DEA) National Prescription Drug Take Back Day has witnessed a considerable turnout. The DEA stated in 2021 that their Take Back Day programs had gathered a total of 15,989,566 pounds (more than 7,995 tons) of prescription medicines since the program's commencement in 2010. This increased awareness and engagement in such programs is generating demand for pharmaceutical waste management services in the region.

Will the Growing Prevalence of Chronic Diseases Boost the Market in the European Region?

Europe region is estimated to exhibit substantial growth within the market during the forecast period. Europe has enacted stringent laws for pharmaceutical waste treatment, resulting in market growth. The European Commission's 2020 pharmaceutical plan intends to minimize the environmental effect of medicines by 30% by 2030. According to the European Medicines Agency (EMA), 88% of new medicine applications in the European Union now include an environmental risk assessment, up from 10% in 2005. This regulatory climate compels pharmaceutical businesses and healthcare facilities to invest in effective waste management solutions.

Furthermore, Europe has a high incidence of pharmaceutical use, which can be attributed in part to its aging population. According to Eurostat data, the proportion of people aged 65 and over is expected to rise from 20.3% in 2019 to 29.4% by 2050. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the European pharmaceutical market is estimated to be worth €213.4 billion in 2020. This high consumption rate, along with an aging population that normally requires more prescriptions, creates a substantial amount of pharmaceutical waste that must be properly managed.

Competitive Landscape

The pharmaceutical waste management market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations focus on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the pharmaceutical waste management market include:

Cardinal Health

Covanta Holding Corporation

US Ecology, Inc.

Stericycle

BioMedical Waste Solution LLC

Dickinson and Company

Waste Management, Inc.

Daniels Health

Sharps Compliance, Inc.

Stryker

Becton

Latest Developments

In February 2021, Cardinal Health WaveMark(TM) Supply Management & Workflow Solutions partnered with HIMSS Analytics(R), a Certified Organization of the Clinically Integrated Supply Outcomes Model (CISOM), to help healthcare systems optimize and benchmark their progress in clinical and operational supply chains.

In February 2023, EcoSteris announced the development of a cutting-edge medical waste plant in Summerville, creating a unique and creative footprint in the business.

In May 2021, UPS Healthcare and Stericycle formed an ongoing relationship to manage medical waste reverse logistics, including trash classification and disposal. UPS and Stericycle hope to provide comprehensive logistical support to the healthcare industry as a result of their collaboration.

Pharmaceutical Waste Management Market, By Category

• Type of Waste:
• Over the counter Waste
• Non-controlled Prescription Drugs
• Controlled Drugs
• Hazardous Drugs
• Nature of Waste:
• Hazardous Pharmaceutical Waste
• Non-hazardous Pharmaceutical Waste
• End User:
• Hospitals
• Pharmacies
• Pharmaceutical & Biotechnology Companies
• Clinics & Physicians' Offices
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 MARKET DEFINITION
• 1.2 MARKET SEGMENTATION
• 1.3 RESEARCH TIMELINES
• 1.4 ASSUMPTIONS
• 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

• 2.1 DATA MINING
• 2.2 SECONDARY RESEARCH
• 2.3 PRIMARY RESEARCH
• 2.4 SUBJECT MATTER EXPERT ADVICE
• 2.5 QUALITY CHECK
• 2.6 FINAL REVIEW
• 2.7 DATA TRIANGULATION
• 2.8 BOTTOM-UP APPROACH
• 2.9 TOP-DOWN APPROACH
• 2.1 RESEARCH FLOW
• 2.11 DATA SOURCES

3 EXECUTIVE SUMMARY

• 3.1 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET OVERVIEW
• 3.2 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT ABSOLUTE MARKET OPPORTUNITY
• 3.3 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET ATTRACTIVENESS, BY REGION
• 3.4 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
• 3.5 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE (USD MILLION)
• 3.6 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE (USD MILLION)
• 3.7 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER (USD MILLION)
• 3.8 FUTURE MARKET OPPORTUNITIES
• 3.9 GLOBAL MARKET SPLIT

4 MARKET OUTLOOK

• 4.1 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET OUTLOOK
• 4.2 MARKET DRIVERS
  • 4.2.1 INCREASING GOVERNMENT INITIATIVES FOR PROPER DISPOSAL OF MEDICATIONS
  • 4.2.2 INCREASING NUMBERS OF THE BOOMER GENERATION
• 4.3 RESTRAINTS
  • 4.3.1 LACK OF AWARENESS ABOUT THE IMPACTS OF IMPROPER DISPOSAL OF MEDICATIONS
  • 4.3.2 HIGH COSTS ASSOCIATED WITH THIS WASTE MANAGEMENT
• 4.4 OPPORTUNITIES
  • 4.4.1 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES ACROSS THE GLOBE TO SUPPORT
• 4.5 IMPACT OF COVID19 ON GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET
• 4.6 MACROECONOMIC ANALYSIS
• 4.7 PORTER'S FIVE FORCES ANALYSIS
  • 4.7.1 THREAT OF NEW ENTRANTS
  • 4.7.2 THREAT OF SUBSTITUTES
  • 4.7.3 BARGAINING POWER OF SUPPLIERS
  • 4.7.4 BARGAINING POWER OF BUYERS
  • 4.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 4.8 VALUE CHAIN ANALYSIS

5 MARKET, BY NATURE OF WASTE

• 5.1 OVERVIEW
• 5.2 HAZARDOUS PHARMACEUTICAL WASTE
• 5.3 NON-HAZARDOUS PHARMACEUTICAL WASTE

6 MARKET, BY TYPE OF WASTE

• 6.1 OVERVIEW
• 6.2 OVER THE COUNTER WASTE
• 6.3 NON-CONTROLLED PRESCRIPTION DRUGS
• 6.4 CONTROLLED DRUGS
• 6.5 HAZARDOUS DRUGS

7 MARKET, BY END USER

• 7.1 OVERVIEW
• 7.2 HOSPITALS
• 7.3 PHARMACIES
• 7.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
• 7.5 CLINICS & PHYSICIANS' OFFICE
• 7.6 OTHERS

8 MARKET, BY GEOGRAPHY

• 8.1 OVERVIEW
• 8.2 NORTH AMERICA
  • 8.2.1 NORTH AMERICA MARKET SNAPSHOT
  • 8.2.2 U.S.
  • 8.2.3 CANADA
  • 8.2.4 MEXICO
• 8.3 EUROPE
  • 8.3.1 EUROPE MARKET SNAPSHOT
  • 8.3.2 GERMANY
  • 8.3.3 U.K.
  • 8.3.4 FRANCE
  • 8.3.5 ITALY
  • 8.3.6 SPAIN
  • 8.3.7 REST OF EUROPE
• 8.4 ASIA PACIFIC
  • 8.4.1 ASIA PACIFIC MARKET SNAPSHOT
  • 8.4.2 CHINA
  • 8.4.3 INDIA
  • 8.4.4 JAPAN
  • 8.4.5 REST OF ASIA PACIFIC
• 8.5 LATIN AMERICA
  • 8.5.1 LATIN AMERICA MARKET SNAPSHOT
  • 8.5.2 BRAZIL
  • 8.5.3 ARGENTINA
  • 8.5.4 REST OF LATIN AMERICA
• 8.6 MIDDLE EAST AND AFRICA
  • 8.6.1 MIDDLE EAST AND AFRICA MARKET SNAPSHOT
  • 8.6.2 UAE
  • 8.6.3 SAUDI ARABIA
  • 8.6.4 SOUTH AFRICA
  • 8.6.5 REST OF MIDDLE EAST AND AFRICA

9 COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 COMPANY MARKET RANKING ANALYSIS
• 9.3 COMPANY REGIONAL FOOTPRINT
• 9.4 COMPANY INDUSTRY FOOTPRINT

10 COMPANY PROFILES

• 10.1 STERICYCLE
  • 10.1.1 COMPANY OVERVIEW
  • 10.1.2 COMPANY INSIGHTS
  • 10.1.3 PRODUCT BENCHMARKING
  • 10.1.4 WINNING IMPERATIVES
  • 10.1.5 CURRENT FOCUS & STRATEGIES
  • 10.1.6 THREAT FROM COMPETITION
  • 10.1.7 SWOT ANALYSIS
• 10.2 DANIELS HEALTH
  • 10.2.1 COMPANY OVERVIEW
  • 10.2.2 COMPANY INSIGHTS
  • 10.2.3 PRODUCT BENCHMARKING
  • 10.2.4 WINNING IMPERATIVES
  • 10.2.5 CURRENT FOCUS & STRATEGIES
  • 10.2.6 THREAT FROM COMPETITION
  • 10.2.7 SWOT ANALYSIS
• 10.3 WASTE MANAGEMENT INC.
  • 10.3.1 COMPANY OVERVIEW
  • 10.3.2 COMPANY INSIGHTS
  • 10.3.3 PRODUCT BENCHMARKING
  • 10.3.4 WINNING IMPERATIVES
  • 10.3.5 CURRENT FOCUS & STRATEGIES
  • 10.3.6 THREAT FROM COMPETITION
  • 10.3.7 SWOT ANALYSIS
• 10.4 CARDINAL HEALTH, INC.
  • 10.4.1 COMPANY OVERVIEW
  • 10.4.2 COMPANY INSIGHTS
  • 10.4.3 SEGMENT BREAKDOWN
  • 10.4.4 PRODUCT BENCHMARKING
• 10.5 COVANTA HOLDING CORPORATION
  • 10.5.1 COMPANY OVERVIEW
  • 10.5.2 COMPANY INSIGHTS
  • 10.5.3 PRODUCT BENCHMARKING
• 10.6 US ECOLOGY, INC.
  • 10.6.1 COMPANY OVERVIEW
  • 10.6.2 COMPANY INSIGHTS
  • 10.6.3 PRODUCT BENCHMARKING
• 10.7 BIOMEDICAL WASTE SOLUTION LLC
  • 10.7.1 COMPANY OVERVIEW
  • 10.7.2 COMPANY INSIGHTS
  • 10.7.3 PRODUCT BENCHMARKING
• 10.8 BECTON, DICKINSON AND COMPANY
  • 10.8.1 COMPANY OVERVIEW
  • 10.8.2 COMPANY INSIGHTS
  • 10.8.3 SEGMENT BREAKDOWN
  • 10.8.4 PRODUCT BENCHMARKING
• 10.9 STRYKER
  • 10.9.1 COMPANY OVERVIEW
  • 10.9.2 COMPANY INSIGHTS
  • 10.9.3 PRODUCT BENCHMARKING
• 10.10 MEDICAL WASTE SERVICE
  • 10.10.1 COMPANY OVERVIEW
  • 10.10.2 COMPANY INSIGHTS
  • 10.10.3 PRODUCT BENCHMARKING